New Data: Little Weight Rebound After Stopping Ozempic, Wegovy

New research challenges fears of quick weight regain after stopping GLP-1 drugs like Ozempic and Wegovy. Real-world data reveals many patients sustain their losses. Experts say durability is possible without lifelong treatment.

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

Real-World Insights Challenge Clinical Trial Findings

Many patients using highly effective GLP-1 drugs may not regain lost weight quickly when they stop treatment. This comes from an analysis of real-world data addressing a key concern about these therapies.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

The data contradicts findings from Novo Nordisk's clinical trials, which warned that many patients regain weight soon after interrupting treatment.

Expert Views on Long-Term Use

Obesity specialists have questioned whether people need these medicines for years to keep benefits.

"The implication of our real-world evidence is not that rebound risk is negligible, but rather that durability is achievable in routine care," said Nference chief scientific officer Venky Soundararajan.

Source Information

Originally published by South China Morning Post.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Medical Insights

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less

New data presented at ENDO 2026 reveals a paradox: patients on GLP-1 medications like Ozempic and Wegovy reduced their physical activity despite losing weight.

8 min read

Medical Research

Popular Weight-Loss Drugs Ozempic and Wegovy May Slow Biological Aging

A new clinical trial suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may help slow biological processes associated with aging in adults with HIV.

8 min read

Health & Wellness

Yes, GLP-1s Make You Thinner. But Do They Make You Freer?

While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.

8 min read

More in GLP-1 Medications

GLP-1 Medications

GLP-1 Drugs Save Airlines $580M Yearly in Fuel Costs

Popular GLP-1 drugs are delivering unexpected savings to airlines, with $580 million in annual fuel cost reductions projected for major U.S. carriers. Analyst Sheila Kahyaoglu's research links passenger weight loss to lower operating expenses. Discover how this weight management trend reshapes aviation economics.

2 min read

GLP-1 Medications

Do GLP-1 Drugs Really Balance Ozempic Face and Weight Loss?

GLP-1 medications like Ozempic drive rapid weight loss but often trigger 'Ozempic face'—a gaunt, sagging facial look from fat volume loss. Do these drugs truly balance the effects? Evidence shows they don't selectively protect facial areas; targeted strategies are essential.

1 min read

GLP-1 Medications

Celebs Showing 'Ozempic Face' from GLP-1 Weight Loss Drugs

Stars using GLP-1 medications like Ozempic for dramatic weight loss are sparking talk of 'Ozempic face': sunken cheeks, new wrinkles, and sagging skin. Cleveland Clinic endocrinologist Vinni Makin notes this gaunt look stems from rapid fat loss. Public figures face scrutiny as the trend grows.

1 min read